US 7,745,606 B2Granted

Immunostimulatory sequence oligonucleotides and methods of using the same

AssigneeDynavax Technologies Corporation

InventorsDino Dina, Karen L. Fearon, Jason Marshall

Life of this patent

Estimating the term…

Abstract

The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.

Claims10

Dependent claims

An isolated polynucleotide consisting essentially of:

5′TCGAACGTTCGAAGATGATGAT-3′ (SEQ ID NO:
171).

Dependencies are inferred from the claim text.

Facts

Application: 10/741,720Filed 18 Dec 2003 · us provisional application
Priority: 23 Dec 2002
Published: US 2006/0058254 A116 Mar 2006
Granted: 29 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification25 codes

C12N 15/117
DNA or RNA fragments; Modified forms thereof ; Non-coding nucleic acids having a biological activity: nucleic acids having immunomodulatory…
A61P 11/02
Drugs for disorders of the respiratory system: nasal agents, e.g. decongestants
A61P 11/06
Drugs for disorders of the respiratory system: antiasthmatics
A61P 17/00
Drugs for dermatological disorders

Family

Application60/436,122Us provisional application · filed 23 Dec 2002
Application60/447,885Us provisional application · filed 13 Feb 2003
Application60/467,546Us provisional application · filed 1 May 2003
US 2006/0058254 A1Pre-grant publication · published 16 Mar 2006
US 7,745,606 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results